{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:51:25Z","timestamp":1793371885111,"version":"4.5.0"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,8,9]],"date-time":"2017-08-09T00:00:00Z","timestamp":1502236800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1038\/nrgastro.2017.104","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T09:33:54Z","timestamp":1502098434000},"page":"652-664","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":291,"title":["Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy"],"prefix":"10.1038","volume":"14","author":[{"given":"Juli\u00e1n","family":"Pan\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Rimola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,9]]},"reference":[{"key":"BFnrgastro2017104_CR1","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00000658-193811000-00007","volume":"108","author":"A Penner","year":"1938","unstructured":"Penner, A. & Crohn, B. B. Perianal fistulae as a complication of regional ileitis. Ann. Surg. 108, 867\u2013873 (1938).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2017104_CR2","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1007\/s10350-007-9006-5","volume":"50","author":"MS Kasparek","year":"2007","unstructured":"Kasparek, M. S. et al. Long-term quality of life in patients with Crohn's disease and perianal fistulas: influence of fecal diversion. Dis. Colon Rectum 50, 2067\u20132074 (2007).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1053\/j.gastro.2005.12.019","volume":"130","author":"L Beaugerie","year":"2006","unstructured":"Beaugerie, L., Seksik, P., Nion-Larmurier, I., Gendre, J. P. & Cosnes, J. Predictors of Crohn's disease. Gastroenterology 130, 650\u2013656 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR4","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.gastro.2003.08.025","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn, W. J., Fazio, V. W., Feagan, B. G., Hanauer, S. B. & American Gastroenterological Association Clinical Practice Committee. AGA technical review on perianal Crohn's disease. Gastroenterology 125, 1508\u20131530 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-0033-1348047","volume":"26","author":"RT Lewis","year":"2013","unstructured":"Lewis, R. T. & Bleier, J. I. Surgical treatment of anorectal Crohn disease. Clin. Colon Rectal Surg. 26, 90\u201399 (2013).","journal-title":"Clin. Colon Rectal Surg."},{"key":"BFnrgastro2017104_CR6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/gast.2002.32362","volume":"122","author":"DA Schwartz","year":"2002","unstructured":"Schwartz, D. A. et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122, 875\u2013880 (2002).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR7","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/DCR.0b013e31825228b0","volume":"55","author":"TW Eglinton","year":"2012","unstructured":"Eglinton, T. W., Barclay, M. L., Gearry, R. B. & Frizelle, F. A. The spectrum of perianal Crohn's disease in a population-based cohort. Dis. Colon Rectum 55, 773\u2013777 (2012).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/gut.21.6.525","volume":"21","author":"G Hellers","year":"1980","unstructured":"Hellers, G., Bergstrand, O., Ewerth, S. & Holmstrom, B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 21, 525\u2013527 (1980).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ibd.20264","volume":"14","author":"S Fields","year":"2008","unstructured":"Fields, S., Rosainz, L., Korelitz, B. I., Panagopoulos, G. & Schneider, J. Rectal strictures in Crohn's disease and coexisting perirectal complications. Inflamm. Bowel Dis. 14, 29\u201331 (2008).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR10","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/0002-9610(80)90048-3","volume":"140","author":"P Buchmann","year":"1980","unstructured":"Buchmann, P., Keighley, M. R., Allan, R. N., Thompson, H. & Alexander-Williams, J. Natural history of perianal Crohn's disease. Ten year follow-up: a plea for conservatism. Am. J. Surg. 140, 642\u2013644 (1980).","journal-title":"Am. J. Surg."},{"key":"BFnrgastro2017104_CR11","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1136\/gut.37.5.696","volume":"37","author":"F Makowiec","year":"1995","unstructured":"Makowiec, F., Jehle, E. C. & Starlinger, M. Clinical course of perianal fistulas in Crohn's disease. Gut 37, 696\u2013701 (1995).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1046\/j.1365-2036.2003.01561.x","volume":"17","author":"SJ Bell","year":"2003","unstructured":"Bell, S. J. et al. The clinical course of fistulating Crohn's disease. Aliment. Pharmacol. Ther. 17, 1145\u20131151 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1067\/msy.2000.108779","volume":"128","author":"F Michelassi","year":"2000","unstructured":"Michelassi, F., Melis, M., Rubin, M. & Hurst, R. D. Surgical treatment of anorectal complications in Crohn's disease. Surgery 128, 597\u2013603 (2000).","journal-title":"Surgery"},{"key":"BFnrgastro2017104_CR14","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/MIB.0000000000000148","volume":"20","author":"I Molendijk","year":"2014","unstructured":"Molendijk, I., Nuij, V. J., van der Meulen-de Jong, A. E. & van der Woude, C. J. Disappointing durable remission rates in complex Crohn's disease fistula. Inflamm. Bowel Dis. 20, 2022\u20132028 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR15","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2036.2004.01917.x","volume":"19","author":"DA Schwartz","year":"2004","unstructured":"Schwartz, D. A. & Herdman, C. R. Review article: The medical treatment of Crohn's perianal fistulas. Aliment. Pharmacol. Ther. 19, 953\u2013967 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR16","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/ibd.21228","volume":"16","author":"I Iesalnieks","year":"2010","unstructured":"Iesalnieks, I. et al. Fistula-associated anal adenocarcinoma in Crohn's disease. Inflamm. Bowel Dis. 16, 1643\u20131648 (2010).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/00365521.2010.536251","volume":"46","author":"JE Baars","year":"2011","unstructured":"Baars, J. E. et al. Malignant transformation of perianal and enterocutaneous fistulas is rare: results of 17 years of follow-up from The Netherlands. Scand. J. Gastroenterol. 46, 319\u2013325 (2011).","journal-title":"Scand. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR18","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijscr.2015.04.013","volume":"10","author":"I Papaconstantinou","year":"2015","unstructured":"Papaconstantinou, I., Mantzos, D. S., Kondi-Pafiti, A. & Koutroubakis, I. E. Anal adenocarcinoma complicating chronic Crohn's disease. Int. J. Surg. Case Rep. 10, 201\u2013203 (2015).","journal-title":"Int. J. Surg. Case Rep."},{"key":"BFnrgastro2017104_CR19","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ecco-jcc\/jjv228","volume":"10","author":"B Siegmund","year":"2016","unstructured":"Siegmund, B. et al. Results of the Fifth Scientific Workshop of the ECCO (II): Pathophysiology of Perianal Fistulizing Disease. J. Crohns Colitis 10, 377\u2013386 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2017104_CR20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gutjnl-2011-300498","volume":"62","author":"M Scharl","year":"2013","unstructured":"Scharl, M. et al. Interleukin-13 and transforming growth factor \u03b2 synergise in the pathogenesis of human intestinal fistulae. Gut 62, 63\u201372 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto, M. A., Huang, R. Y., Jackson, R. A. & Thiery, J. P. Emt: 2016. Cell 166, 21\u201345 (2016).","journal-title":"Cell"},{"key":"BFnrgastro2017104_CR22","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1097\/01.MIB.0000435760.82705.23","volume":"19","author":"SM Frei","year":"2013","unstructured":"Frei, S. M. et al. A role for tumor necrosis factor and bacterial antigens in the pathogenesis of Crohn's disease-associated fistulae. Inflamm. Bowel Dis. 19, 2878\u20132887 (2013).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR23","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/ibd.21555","volume":"17","author":"M Scharl","year":"2011","unstructured":"Scharl, M. et al. Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae. Inflamm. Bowel Dis. 17, 1907\u20131916 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR24","doi-asserted-by":"crossref","first-page":"e78882","DOI":"10.1371\/journal.pone.0078882","volume":"8","author":"SM Frei","year":"2013","unstructured":"Frei, S. M. et al. The role for dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae. PLoS ONE 8, e78882 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrgastro2017104_CR25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/MEG.0b013e32836371a2","volume":"26","author":"M Scharl","year":"2014","unstructured":"Scharl, M. et al. Epithelial-to-mesenchymal transition in a fistula-associated anal adenocarcinoma in a patient with long-standing Crohn's disease. Eur. J. Gastroenterol. Hepatol. 26, 114\u2013118 (2014).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"BFnrgastro2017104_CR26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/gut.47.1.63","volume":"47","author":"B von Lampe","year":"2000","unstructured":"von Lampe, B., Barthel, B., Coupland, S. E., Riecken, E. O. & Rosewicz, S. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease. Gut 47, 63\u201373 (2000).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR27","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1053\/j.gastro.2005.09.017","volume":"129","author":"FE Castaneda","year":"2005","unstructured":"Castaneda, F. E. et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology 129, 1991\u20132008 (2005).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/gut.2003.017442","volume":"53","author":"T Kirkegaard","year":"2004","unstructured":"Kirkegaard, T., Hansen, A., Bruun, E. & Brynskov, J. Expression and localisation of matrix metalloproteinases and their natural inhibitors in fistulae of patients with Crohn's disease. Gut 53, 701\u2013709 (2004).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR29","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/bjs.1800790107","volume":"79","author":"F Seow-Choen","year":"1992","unstructured":"Seow-Choen, F., Hay, A. J., Heard, S. & Phillips, R. K. Bacteriology of anal fistulae. Br. J. Surg. 79, 27\u201328 (1992).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro2017104_CR30","first-page":"S81","volume":"9","author":"NA Yassin","year":"2015","unstructured":"Yassin, N. A. et al. The gut microbiome\u2013immune system interaction as an aetiological factor for fistulising perianal Crohn's disease. J. Crohns Colitis 9, S81\u2013S82 (2015).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2017104_CR31","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1136\/gutjnl-2011-300777","volume":"62","author":"I Cleynen","year":"2013","unstructured":"Cleynen, I. et al. Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European Project. Gut 62, 1556\u20131565 (2013).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR32","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.cgh.2009.05.001","volume":"7","author":"L Henckaerts","year":"2009","unstructured":"Henckaerts, L. et al. Genetic risk profiling and prediction of disease course in Crohn's disease patients. Clin. Gastroenterol. Hepatol. 7, 972\u2013980.e2 (2009).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2017104_CR33","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/MIB.0000000000000705","volume":"22","author":"M Kaur","year":"2016","unstructured":"Kaur, M. et al. Perianal Crohn's disease is associated with distal colonic disease, stricturing disease behavior, IBD-associated serologies and genetic variation in the JAK\u2013STAT pathway. Inflamm. Bowel Dis. 22, 862\u2013869 (2016).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/bjs.1800630102","volume":"63","author":"AG Parks","year":"1976","unstructured":"Parks, A. G., Gordon, P. H. & Hardcastle, J. D. A classification of fistula-in-ano. Br. J. Surg. 63, 1\u201312 (1976).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro2017104_CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2214\/ajr.167.3.8751692","volume":"167","author":"JA Spencer","year":"1996","unstructured":"Spencer, J. A., Ward, J., Beckingham, I. J., Adams, C. & Ambrose, N. S. Dynamic contrast-enhanced MR imaging of perianal fistulas. AJR Am. J. Roentgenol. 167, 735\u2013741 (1996).","journal-title":"AJR Am. J. Roentgenol."},{"key":"BFnrgastro2017104_CR36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiographics.20.3.g00mc15623","volume":"20","author":"J Morris","year":"2000","unstructured":"Morris, J., Spencer, J. A. & Ambrose, N. S. MR imaging classification of perianal fistulas and its implications for patient management. Radiographics 20, 623\u2013635 (2000).","journal-title":"Radiographics"},{"key":"BFnrgastro2017104_CR37","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/ibd.21940","volume":"18","author":"P Tozer","year":"2012","unstructured":"Tozer, P. et al. Long-term MRI-guided combined anti-TNF-\u03b1 and thiopurine therapy for Crohn's perianal fistulas. Inflamm. Bowel Dis. 18, 1825\u20131834 (2012).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR38","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1148\/radiol.2016151491","volume":"282","author":"SP Sheedy","year":"2017","unstructured":"Sheedy, S. P., Bruining, D. H., Dozois, E. J., Faubion, W. A. & Fletcher, J. G. MR imaging of perianal Crohn disease. Radiology 282, 628\u2013645 (2017).","journal-title":"Radiology"},{"key":"BFnrgastro2017104_CR39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199501000-00008","volume":"20","author":"EJ Irvine","year":"1995","unstructured":"Irvine, E. J. Usual therapy improves perianal Crohn's disease as measured by a new disease activity index. McMaster IBD Study Group. J. Clin. Gastroenterol. 20, 27\u201332 (1995).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2017104_CR40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/BF02053756","volume":"35","author":"A Allan","year":"1992","unstructured":"Allan, A., Linares, L., Spooner, H. A. & Alexander-Williams, J. Clinical index to quantitate symptoms of perianal Crohn's disease. Dis. Colon Rectum 35, 656\u2013661 (1992).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR41","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1038\/ajg.2009.509","volume":"104","author":"SC Ng","year":"2009","unstructured":"Ng, S. C. et al. Prospective evaluation of anti-tumor necrosis factor therapy guided by magnetic resonance imaging for Crohn's perineal fistulas. Am. J. Gastroenterol. 104, 2973\u20132986 (2009).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR42","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.clinimag.2010.09.003","volume":"35","author":"K Horsthuis","year":"2011","unstructured":"Horsthuis, K. et al. Evaluation of an MRI-based score of disease activity in perianal fistulizing Crohn's disease. Clin. Imag. 35, 360\u2013365 (2011).","journal-title":"Clin. Imag."},{"key":"BFnrgastro2017104_CR43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0002-9270(02)05909-9","volume":"98","author":"G Van Assche","year":"2003","unstructured":"Van Assche, G. et al. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease. Am. J. Gastroenterol. 98, 332\u2013339 (2003).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR44","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1148\/radiol.2512072128","volume":"251","author":"K Horsthuis","year":"2009","unstructured":"Horsthuis, K., Lavini, C., Bipat, S., Stokkers, P. C. & Stoker, J. Perianal Crohn disease: evaluation of dynamic contrast-enhanced MR imaging as an indicator of disease activity. Radiology 251, 380\u2013387 (2009).","journal-title":"Radiology"},{"key":"BFnrgastro2017104_CR45","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cgh.2010.10.022","volume":"9","author":"K Karmiris","year":"2011","unstructured":"Karmiris, K. et al. Long-term monitoring of infliximab therapy for perianal fistulizing Crohn's disease by using magnetic resonance imaging. Clin. Gastroenterol. Hepatol. 9, 130\u2013136 (2011).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2017104_CR46","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1002\/ibd.21568","volume":"17","author":"C Savoye-Collet","year":"2011","unstructured":"Savoye-Collet, C., Savoye, G., Koning, E., Dacher, J. N. & Lerebours, E. Fistulizing perianal Crohn's disease: contrast-enhanced magnetic resonance imaging assessment at 1 year on maintenance anti-TNF-\u03b1 therapy. Inflamm. Bowel Dis. 17, 1751\u20131758 (2011).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/gast.2001.28676","volume":"121","author":"DA Schwartz","year":"2001","unstructured":"Schwartz, D. A. et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn's perianal fistulas. Gastroenterology 121, 1064\u20131072 (2001).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/MIB.0000000000000378","volume":"21","author":"A Fichera","year":"2015","unstructured":"Fichera, A., Zoccali, M. & Crohn's & Colitis Foundation of America, Inc. Guidelines for the surgical treatment of Crohn's perianal fistulas. Inflamm. Bowel Dis. 21, 753\u2013758 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/MIB.0000000000000315","volume":"21","author":"DA Schwartz","year":"2015","unstructured":"Schwartz, D. A. et al. Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement. Inflamm. Bowel Dis. 21, 723\u2013730 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR50","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","volume":"63","author":"KB Gecse","year":"2014","unstructured":"Gecse, K. B. et al. A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease. Gut 63, 1381\u20131392 (2014).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1097\/MIB.0000000000000377","volume":"21","author":"DA Schwartz","year":"2015","unstructured":"Schwartz, D. A., Ghazi, L. J. & Regueiro, M. Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials. Inflamm. Bowel Dis. 21, 737\u2013752 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomollon","year":"2017","unstructured":"Gomollon, F. et al. 3 rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 1: diagnosis and medical management. J. Crohns Colitis 11, 3\u201325 (2017).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2017104_CR53","first-page":"603","volume":"35","author":"TA Hinterleitner","year":"1997","unstructured":"Hinterleitner, T. A. et al. Combination of cyclosporine, azathioprine and prednisolone for perianal fistulas in Crohn's disease. Z. Gastroenterol. 35, 603\u2013608 (1997).","journal-title":"Z. Gastroenterol."},{"key":"BFnrgastro2017104_CR54","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/gut.24.3.177","volume":"24","author":"JE Lennard-Jones","year":"1983","unstructured":"Lennard-Jones, J. E. Toward optimal use of corticosteroids in ulcerative colitis and Crohn's disease. Gut 24, 177\u2013181 (1983).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR55","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0016-5085(82)80332-6","volume":"83","author":"LJ Brandt","year":"1982","unstructured":"Brandt, L. J., Bernstein, L. H., Boley, S. J. & Frank, M. S. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83, 383\u2013387 (1982).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR56","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1155\/1993\/610272","volume":"7","author":"MJ Solomon","year":"1993","unstructured":"Solomon, M. J. et al. Combination of ciprofloxacin and metronidazole in severe perianal Crohn's disease. Can. J. Gastroenterol. 7, 571\u2013573 (1993).","journal-title":"Can. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR57","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ibd.20608","volume":"15","author":"KT Thia","year":"2009","unstructured":"Thia, K. T. et al. Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: a randomized, double-blind, placebo-controlled pilot study. Inflamm. Bowel Dis. 15, 17\u201324 (2009).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR58","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/bjs.7121","volume":"97","author":"Y Maeda","year":"2010","unstructured":"Maeda, Y. et al. Randomized clinical trial of metronidazole ointment versus placebo in perianal Crohn's disease. Br. J. Surg. 97, 1340\u20131347 (2010).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro2017104_CR59","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1365-2036.2004.02247.x","volume":"20","author":"RL West","year":"2004","unstructured":"West, R. L. et al. Clinical and endosonographic effect of ciprofloxacin on the treatment of perianal fistulae in Crohn's disease with infliximab: a double-blind placebo-controlled study. Aliment. Pharmacol. Ther. 20, 1329\u20131336 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR60","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1136\/gutjnl-2013-304488","volume":"63","author":"P Dewint","year":"2014","unstructured":"Dewint, P. et al. Adalimumab combined with ciprofloxacin is superior to adalimumab monotherapy in perianal fistula closure in Crohn's disease: a randomised, double-blind, placebo controlled trial (ADAFI). Gut 63, 292\u2013299 (2014).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR61","doi-asserted-by":"crossref","first-page":"132","DOI":"10.7326\/0003-4819-123-2-199507150-00009","volume":"123","author":"DC Pearson","year":"1995","unstructured":"Pearson, D. C., May, G. R., Fick, G. H. & Sutherland, L. R. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann. Intern. Med. 123, 132\u2013142 (1995).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2017104_CR62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","volume":"18","author":"C Dejaco","year":"2003","unstructured":"Dejaco, C. et al. Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease. Aliment. Pharmacol. Ther. 18, 1113\u20131120 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR63","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0016-5085(03)00877-1","volume":"125","author":"WJ Sandborn","year":"2003","unstructured":"Sandborn, W. J. et al. Tacrolimus for the treatment of fistulas in patients with Crohn's disease: a randomized, placebo-controlled trial. Gastroenterology 125, 380\u2013388 (2003).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR64","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/ibd.20073","volume":"13","author":"AL Hart","year":"2007","unstructured":"Hart, A. L., Plamondon, S. & Kamm, M. A. Topical tacrolimus in the treatment of perianal Crohn's disease: exploratory randomized controlled trial. Inflamm. Bowel Dis. 13, 245\u2013253 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR65","first-page":"646","volume":"88","author":"SB Hanauer","year":"1993","unstructured":"Hanauer, S. B. & Smith, M. B. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am. J. Gastroenterol. 88, 646\u2013649 (1993).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR66","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF02090211","volume":"39","author":"DH Present","year":"1994","unstructured":"Present, D. H. & Lichtiger, S. Efficacy of cyclosporine in treatment of fistula of Crohn's disease. Dig. Dis. Sci. 39, 374\u2013380 (1994).","journal-title":"Dig. Dis. Sci."},{"key":"BFnrgastro2017104_CR67","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1046\/j.1365-2036.2003.01790.x","volume":"18","author":"U Mahadevan","year":"2003","unstructured":"Mahadevan, U., Marion, J. F. & Present, D. H. Fistula response to methotrexate in Crohn's disease: a case series. Aliment. Pharmacol. Ther. 18, 1003\u20131008 (2003).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR68","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2036.2004.01850.x","volume":"19","author":"O Schroder","year":"2004","unstructured":"Schroder, O., Blumenstein, I., Schulte-Bockholt, A. & Stein, J. Combining infliximab and methotrexate in fistulizing Crohn's disease resistant or intolerant to azathioprine. Aliment. Pharmacol. Ther. 19, 295\u2013301 (2004).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR69","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1056\/NEJM199905063401804","volume":"340","author":"DH Present","year":"1999","unstructured":"Present, D. H. et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N. Engl. J. Med. 340, 1398\u20131405 (1999).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017104_CR70","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","volume":"350","author":"BE Sands","year":"2004","unstructured":"Sands, B. E. et al. Infliximab maintenance therapy for fistulizing Crohn's disease. N. Engl. J. Med. 350, 876\u2013885 (2004).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017104_CR71","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1053\/j.gastro.2005.11.030","volume":"130","author":"SB Hanauer","year":"2006","unstructured":"Hanauer, S. B. et al. Human anti-tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I trial. Gastroenterology 130, 323\u2013333 (2006).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR72","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-146-12-200706190-00159","volume":"146","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn, W. J. et al. Adalimumab induction therapy for Crohn disease previously treated with infliximab: a randomized trial. Ann. Intern. Med. 146, 829\u2013838 (2007).","journal-title":"Ann. Intern. Med."},{"key":"BFnrgastro2017104_CR73","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/gut.2008.159251","volume":"58","author":"JF Colombel","year":"2009","unstructured":"Colombel, J. F. et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut 58, 940\u2013948 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa067594","volume":"357","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn, W. J. et al. Certolizumab pegol for the treatment of Crohn's disease. N. Engl. J. Med. 357, 228\u2013238 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017104_CR75","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","volume":"357","author":"S Schreiber","year":"2007","unstructured":"Schreiber, S. et al. Maintenance therapy with certolizumab pegol for Crohn's disease. N. Engl. J. Med. 357, 239\u2013250 (2007).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017104_CR76","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2036.2010.04509.x","volume":"33","author":"S Schreiber","year":"2011","unstructured":"Schreiber, S. et al. Randomised clinical trial: certolizumab pegol for fistulas in Crohn's disease - subgroup results from a placebo-controlled study. Aliment. Pharmacol. Ther. 33, 185\u2013193 (2011).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR77","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.cgh.2012.12.042","volume":"11","author":"G Bouguen","year":"2013","unstructured":"Bouguen, G. et al. Long-term outcome of perianal fistulizing Crohn's disease treated with infliximab. Clin. Gastroenterol. Hepatol. 11, 975\u2013981.e1-4 (2013).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"BFnrgastro2017104_CR78","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1215739","volume":"369","author":"WJ Sandborn","year":"2013","unstructured":"Sandborn, W. J. et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N. Engl. J. Med. 369, 711\u2013721 (2013).","journal-title":"N. Engl. J. Med."},{"key":"BFnrgastro2017104_CR79","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0016-5085(99)70276-3","volume":"117","author":"ED Ehrenpreis","year":"1999","unstructured":"Ehrenpreis, E. D., Kane, S. V., Cohen, L. B., Cohen, R. D. & Hanauer, S. B. Thalidomide therapy for patients with refractory Crohn's disease: An open-label trial. Gastroenterology 117, 1271\u20131277 (1999).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR80","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00004836-199410000-00006","volume":"19","author":"A Lavy","year":"1994","unstructured":"Lavy, A. et al. Hyperbaric oxygen for perianal Crohn's disease. J. Clin. Gastroenterol. 19, 202\u2013205 (1994).","journal-title":"J. Clin. Gastroenterol."},{"key":"BFnrgastro2017104_CR81","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/BF02054120","volume":"38","author":"JF Colombel","year":"1995","unstructured":"Colombel, J. F. et al. Hyperbaric oxygenation in severe perineal Crohn's disease. Dis. Colon Rectum 38, 609\u2013614 (1995).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR82","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1023\/A:1027378532003","volume":"17","author":"G Weisz","year":"1997","unstructured":"Weisz, G. et al. Modification of in vivo and in vitro TNF-\u03b1, IL-1, and IL-6 secretion by circulating monocytes during hyperbaric oxygen treatment in patients with perianal Crohn's disease. J. Clin. Immunol. 17, 154\u2013159 (1997).","journal-title":"J. Clin. Immunol."},{"key":"BFnrgastro2017104_CR83","first-page":"1721","volume":"103","author":"Y Fukuda","year":"2008","unstructured":"Fukuda, Y. et al. Oral spherical adsorptive carbon for the treatment of intractable anal fistulas in Crohn's disease: a multicenter, randomized, double-blind, placebo-controlled trial. Am. J. Gastroenterol. 103, 1721\u20131729 (2008).","journal-title":"Am. J. Gastroenterol."},{"key":"BFnrgastro2017104_CR84","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1097\/MIB.0000000000000031","volume":"20","author":"W Reinisch","year":"2014","unstructured":"Reinisch, W. et al. AST-120 (spherical carbon adsorbent) in the treatment of perianal fistulae in mild-to-moderate Crohn's disease: FHAST-1, a phase 3, multicenter, placebo-controlled study. Inflamm. Bowel Dis. 20, 872\u2013881 (2014).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1749-6632.2009.04607.x","volume":"1176","author":"ME Bernardo","year":"2009","unstructured":"Bernardo, M. E., Locatelli, F. & Fibbe, W. E. Mesenchymal stromal cells. Ann. NY Acad. Sci. 1176, 101\u2013117 (2009).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrgastro2017104_CR86","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1182\/blood-2007-02-069716","volume":"110","author":"AJ Nauta","year":"2007","unstructured":"Nauta, A. J. & Fibbe, W. E. Immunomodulatory properties of mesenchymal stromal cells. Blood 110, 3499\u20133506 (2007).","journal-title":"Blood"},{"key":"BFnrgastro2017104_CR87","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","volume":"58","author":"E Gonzalez-Rey","year":"2009","unstructured":"Gonzalez-Rey, E., Gonzalez, M. A., Rico, L., Buscher, D. & Delgado, M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut 58, 929\u2013939 (2009).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR88","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1586\/eci.10.27","volume":"6","author":"J Panes","year":"2010","unstructured":"Panes, J., Ordas, I. & Ricart, E. Stem cell treatment for Crohn's disease. Expert Rev. Clin. Immunol. 6, 597\u2013605 (2010).","journal-title":"Expert Rev. Clin. Immunol."},{"key":"BFnrgastro2017104_CR89","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garcia-Olmo","year":"2005","unstructured":"Garcia-Olmo, D. et al. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis. Colon Rectum. 48, 1416\u20131423 (2005).","journal-title":"Dis. Colon Rectum."},{"key":"BFnrgastro2017104_CR90","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/DCR.0b013e3181973487","volume":"52","author":"D Garcia-Olmo","year":"2009","unstructured":"Garcia-Olmo, D. et al. Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Dis. Colon Rectum. 52, 79\u201386 (2009).","journal-title":"Dis. Colon Rectum."},{"key":"BFnrgastro2017104_CR91","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00384-011-1350-1","volume":"27","author":"H Guadalajara","year":"2012","unstructured":"Guadalajara, H. et al. Long-term follow-up of patients undergoing adipose-derived adult stem cell administration to treat complex perianal fistulas. Int. J. Colorectal Dis. 27, 595\u2013600 (2012).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro2017104_CR92","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","volume":"60","author":"R Ciccocioppo","year":"2011","unstructured":"Ciccocioppo, R. et al. Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulizing Crohn's disease. Gut 60, 788\u2013798 (2011).","journal-title":"Gut"},{"key":"BFnrgastro2017104_CR93","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","volume":"28","author":"F de la Portilla","year":"2013","unstructured":"de la Portilla, F. et al. Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn's disease: results from a multicenter phase I\/IIa clinical trial. Int. J. Colorectal Dis. 28, 313\u2013323 (2013).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro2017104_CR94","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","volume":"149","author":"I Molendijk","year":"2015","unstructured":"Molendijk, I. et al. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn's disease. Gastroenterology 149, 918\u2013927.e6 (2015).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR95","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","volume":"388","author":"J Panes","year":"2016","unstructured":"Panes, J. et al. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet 388, 1281\u20131290 (2016).","journal-title":"Lancet"},{"key":"BFnrgastro2017104_CR96","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","volume":"153","author":"AB Dietz","year":"2017","unstructured":"Dietz, A. B. et al. Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease. Gastroenterology 153, 59\u201362.e2 (2017).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR97","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s003840050051","volume":"11","author":"MJ Solomon","year":"1996","unstructured":"Solomon, M. J. Fistulae and abscesses in symptomatic perianal Crohn's disease. Int. J. Colorectal Dis. 11, 222\u2013226 (1996).","journal-title":"Int. J. Colorectal Dis."},{"key":"BFnrgastro2017104_CR98","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/00054725-200303000-00003","volume":"9","author":"M Regueiro","year":"2003","unstructured":"Regueiro, M. & Mardini, H. Treatment of perianal fistulizing Crohn's disease with infliximab alone or as an adjunct to exam under anesthesia with seton placement. Inflamm. Bowel Dis. 9, 98\u2013103 (2003).","journal-title":"Inflamm. Bowel Dis."},{"key":"BFnrgastro2017104_CR99","first-page":"299","volume":"53","author":"G Sciaudone","year":"2010","unstructured":"Sciaudone, G. et al. Treatment of complex perianal fistulas in Crohn disease: infliximab, surgery or combined approach. Can. J. Surg. 53, 299\u2013304 (2010).","journal-title":"Can. J. Surg."},{"key":"BFnrgastro2017104_CR100","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF02590942","volume":"19","author":"AG Parks","year":"1976","unstructured":"Parks, A. G. & Stitz, R. W. The treatment of high fistula-in-ano. Dis. Colon Rectum 19, 487\u2013499 (1976).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR101","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s10350-006-0656-5","volume":"49","author":"SA Hyder","year":"2006","unstructured":"Hyder, S. A., Travis, S. P., Jewell, D. P., McC Mortensen, N. J. & George, B. D. Fistulating anal Crohn's disease: results of combined surgical and infliximab treatment. Dis. Colon Rectum 49, 1837\u20131841 (2006).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR102","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/bjs.6608","volume":"96","author":"PJ van Koperen","year":"2009","unstructured":"van Koperen, P. J., Safiruddin, F., Bemelman, W. A. & Slors, J. F. Outcome of surgical treatment for fistula in ano in Crohn's disease. Br. J. Surg. 96, 675\u2013679 (2009).","journal-title":"Br. J. Surg."},{"key":"BFnrgastro2017104_CR103","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF02053687","volume":"34","author":"JG Williams","year":"1991","unstructured":"Williams, J. G., Rothenberger, D. A., Nemer, F. D. & Goldberg, S. M. Fistula-in-ano in Crohn's disease. Results of aggressive surgical treatment. Dis. Colon Rectum 34, 378\u2013384 (1991).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR104","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1463-1318.2009.01811.x","volume":"12","author":"V de Parades","year":"2010","unstructured":"de Parades, V. et al. Seton drainage and fibrin glue injection for complex anal fistulas. Colorectal Dis. 12, 459\u2013463 (2010).","journal-title":"Colorectal Dis."},{"key":"BFnrgastro2017104_CR105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1463-1318.2010.02234.x","volume":"13","author":"WB Gaertner","year":"2011","unstructured":"Gaertner, W. B. et al. Results of combined medical and surgical treatment of recto-vaginal fistula in Crohn's disease. Colorectal Dis. 13, 678\u2013683 (2011).","journal-title":"Colorectal Dis."},{"key":"BFnrgastro2017104_CR106","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF02050009","volume":"36","author":"ME Abel","year":"1993","unstructured":"Abel, M. E., Chiu, Y. S., Russell, T. R. & Volpe, P. A. Autologous fibrin glue in the treatment of rectovaginal and complex fistulas. Dis. Colon Rectum 36, 447\u2013449 (1993).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR107","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s10350-004-6612-3","volume":"46","author":"O Zmora","year":"2003","unstructured":"Zmora, O. et al. Fibrin glue sealing in the treatment of perineal fistulas. Dis. Colon Rectum 46, 584\u2013589 (2003).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR108","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s10350-003-0076-8","volume":"47","author":"R Loungnarath","year":"2004","unstructured":"Loungnarath, R. et al. Fibrin glue treatment of complex anal fistulas has low success rate. Dis. Colon Rectum 47, 432\u2013436 (2004).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR109","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s10350-004-7247-0","volume":"45","author":"I Lindsey","year":"2002","unstructured":"Lindsey, I., Smilgin-Humphreys, M. M., Cunningham, C., Mortensen, N. J. & George, B. D. A randomized, controlled trial of fibrin glue versus conventional treatment for anal fistula. Dis. Colon Rectum 45, 1608\u20131615 (2002).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR110","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1053\/j.gastro.2010.02.013","volume":"138","author":"JC Grimaud","year":"2010","unstructured":"Grimaud, J. C. et al. Fibrin glue is effective healing perianal fistulas in patients with Crohn's disease. Gastroenterology 138, 2275\u20132281.e1 (2010).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR111","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s10350-004-0898-z","volume":"48","author":"M Singer","year":"2005","unstructured":"Singer, M. et al. Treatment of fistulas-in-ano with fibrin sealant in combination with intra-adhesive antibiotics and\/or surgical closure of the internal fistula opening. Dis. Colon Rectum 48, 799\u2013808 (2005).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/DCR.0b013e318239d1e4","volume":"55","author":"JM O'Riordan","year":"2012","unstructured":"O'Riordan, J. M., Datta, I., Johnston, C. & Baxter, N. N. A systematic review of the anal fistula plug for patients with Crohn's and non-Crohn's related fistula-in-ano. Dis. Colon Rectum 55, 351\u2013358 (2012).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR113","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/ecco-jcc\/jjv162","volume":"10","author":"A Senejoux","year":"2016","unstructured":"Senejoux, A. et al. Fistula plug in fistulising ano-perineal Crohn's disease: a randomised controlled trial. J. Crohns Colitis 10, 141\u2013148 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2017104_CR114","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/DCR.0b013e3181ce8b01","volume":"53","author":"A Soltani","year":"2010","unstructured":"Soltani, A. & Kaiser, A. M. Endorectal advancement flap for cryptoglandular or Crohn's fistula-in-ano. Dis. Colon Rectum 53, 486\u2013495 (2010).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/ecco-jcc\/jjw169","volume":"11","author":"P Gionchetti","year":"2016","unstructured":"Gionchetti, P. et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn's disease 2016: Part 2: Surgical management and special situations. J. Crohns Colitis 11, 135\u2013149 (2016).","journal-title":"J. Crohns Colitis"},{"key":"BFnrgastro2017104_CR116","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10151-009-0522-2","volume":"13","author":"A Rojanasakul","year":"2009","unstructured":"Rojanasakul, A. LIFT procedure: a simplified technique for fistula-in-ano. Tech. Coloproctol. 13, 237\u2013240 (2009).","journal-title":"Tech. Coloproctol."},{"key":"BFnrgastro2017104_CR117","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/SLA.0000000000000479","volume":"260","author":"DS Gingold","year":"2014","unstructured":"Gingold, D. S., Murrell, Z. A. & Fleshner, P. R. A prospective evaluation of the ligation of the intersphincteric tract procedure for complex anal fistula in patients with Crohn's disease. Ann. Surg. 260, 1057\u20131061 (2014).","journal-title":"Ann. Surg."},{"key":"BFnrgastro2017104_CR118","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","volume":"114","author":"GR D'Haens","year":"1998","unstructured":"D'Haens, G. R. et al. Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114, 262\u2013267 (1998).","journal-title":"Gastroenterology"},{"key":"BFnrgastro2017104_CR119","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s002680010250","volume":"24","author":"T Yamamoto","year":"2000","unstructured":"Yamamoto, T., Allan, R. N. & Keighley, M. R. Effect of fecal diversion alone on perianal Crohn's disease. World J. Surg. 24, 1258\u20131262; discussion 1262\u20131263 (2000).","journal-title":"World J. Surg."},{"key":"BFnrgastro2017104_CR120","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/apt.13356","volume":"42","author":"S Singh","year":"2015","unstructured":"Singh, S. et al. Systematic review with meta-analysis: faecal diversion for management of perianal Crohn's disease. Aliment. Pharmacol. Ther. 42, 783\u2013792 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"BFnrgastro2017104_CR121","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1007\/s10350-007-9077-3","volume":"50","author":"WB Gaertner","year":"2007","unstructured":"Gaertner, W. B. et al. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas? Dis. Colon Rectum 50, 1754\u20131760 (2007).","journal-title":"Dis. Colon Rectum"},{"key":"BFnrgastro2017104_CR122","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1093\/ecco-jcc\/jjw039","volume":"10","author":"KB Gecse","year":"2016","unstructured":"Gecse, K. B. et al. Results of the Fifth Scientific Workshop of the ECCO [II]: clinical aspects of perianal fistulising crohn's disease-the unmet needs. J. Crohns Colitis 10, 758\u2013765 (2016).","journal-title":"J. Crohns Colitis"}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrgastro.2017.104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrgastro.2017.104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:57:10Z","timestamp":1684468630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrgastro.2017.104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,9]]},"references-count":122,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["BFnrgastro2017104"],"URL":"https:\/\/doi.org\/10.1038\/nrgastro.2017.104","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,9]]},"assertion":[{"value":"9 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P. has received consulting fees from Abbvie, Almirall, Boehringer-Ingelheim, Celgene, Ferring, Janssen, MSD, Novartis, Pfizer, Robarts, Roche, Second Genome, Shire, Takeda, TiGenix and Topivert; and speaker fees from Abbvie, Biogen, Ferring, Janssen, MSD and Pfizer. J.R. has received consulting and speaker fees from Abbvie, Bioclinica, Boehringer-Ingelheim, MSD, Robarts Clinical Trials, Roche, Takeda, and TiGenix.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}